References
Dawson Hughes B. The role of calcium in the treatment of osteoporosis. In: ‘Osteoporosis’ Marcus R, Feldman D, Kelsey J, editors. Osteoporosis San Diego: Academic Press, 1996:1159–68.
Orwoll ES. The effects of dietary protein insufficiency and excess on skeletal health. Bone 1992;13:343–50.
Bonjour JP, Schilrch MA, Rizzoli R. Nutritional aspects of hip fractures. Bone 1996; 18 (Suppl): S 139–44.
Recommended Daily Allowances. National Research Council (US). 10th ed. Washington, DC: National Academy Press, 1989.
Pellett PL. Protein requirements in humans. Am J Clin Nutr 1990;51:723–37.
Canalis E, Agnusdei D. Insulin-like growth factors and their role in osteoporosis. Calcif Tissue Int 1996;58:133–4.
Rosen C. Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon’s fountain revisited? J Cell Biochem 1994;56:348–56.
Rosen CJ, Donahue LR. Insulin-like growth factors: potential therapeutic options for osteoporosis. Trends Endocrinol Metab 1995;6:235–41.
Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983;71:175–82.
Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80–101.
Thissen JP, Triest S, Maes M, Underwood LE, Ketelslegers JM. The decreased plasma concentrations of insulin-like growth factor-1 in protein-restricted rats is not due to decreased number of growth hormone receptors on isolated hepatocytes. J Endocrinol 1990;124:159–65.
VandeHaar MJ, Moats-Staats BM, Davenport ML, Walker JL, Ketelslegers JM, Sharma BK, et al. Reduced serum concentrations of insulin-like growth factor-1 in protein-restricted growing rats are accompanied by reduced IGF-1 mRNA levels in liver and skeletal muscle. J Endocrinol 1991;130:305–12.
Thissen JP, Davenport ML, Pucilowska J, Miles MV, Underwood LE. Increased serum clearance and degradation of (125I)-labeled IGF-1 in protein-restricted rats. Am J Physiol 1992;262:E406–11.
Thissen JP, Triest S, Moats-Staats BM, et al. Evidence that pretranslational and translational defects decrease serum insulinlike growth factor-1 concentrations during dietary protein restriction. Endocrinology 1991;129:429–35.
Maker D, Fliesen T, Underwood LE, Maes M, Gerard G, Davenport ML, et al. Dietary protein restriction decreases insulinlike growth factor-1 independent of insulin and liver growth hormone binding. Endocrinology 1989;124:2604–11.
Straus DS, Takemoto CD. Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and (IGF)-II, IGF binding protein-2, and serum albumin gene expression in rat. Endocrinology 1990;127:1849–60.
Harp JB, Goldstein S, Phillips LS. Molecular regulation of IGF-1 by amino acid availability in cultured hepatocytes. Diabetes 1991;40:95–101.
Pucilowska JB, Davenport ML, Kabir I, et al. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis. J Clin Endocrinol Metab 1993;77:1516–21.
Hill KK, Hill DB, McClain MP, Humphries LL, McClain CJ. Serum insulin-like growth factor-1 concentrations in the recovery of patients with anorexia nervosa. J Am Coll Nutr 1993;4:475–8.
Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of insulin-like growth factor-1. Metabolism 1995;44:50–7.
Clemmons DR, Underwood LE, Dickerson RN, et al. Use of plasma somatomedin-C/insulin-like growth factor-1 measurements to monitor the response to nutritional repletion on malnourished patients. Am J Clin Nutr 1985;41:191–8.
Thissen JP, Underwood LE, Maiter D, Maes M, Clemmons DR, Ketelslegers JM. Failure of insulin-like growth factor-1 (IGF-1) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-1 concentrations. Endocrinology 1991;128:885–90.
Kurose H, Yamaoka K, Okada S, Nakajima S, Seino Y. 1,25-Dihydroxyvitamin-D3 increases insulin-like growth factor-1 receptors in clonal osteoblastic cells: study on interaction of IGF-1 and l,25-(OH)2d3. Endocrinology 1990;126:2088–94.
Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, et al. The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 1992;74:24–7.
Straus DS, Burke EJ, Marten NW. Induction of insulin-like growth factor binding protein-1 gene expression in liver of protein-restricted rats and in rat hepatoma cells limited for a single amino acid. Endocrinology 1993;132:1090–100.
Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-1) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 1995;80:443–9.
Schüren MA, Rizzoli R, Vadas L, Slosman DO, Bonjour JP. Protein supplements in elderly with a recent hip fracture increase serum IGF-1, decrease urinary deoxypyridinoline, and prevent proximal femur bone loss. J Bone Miner Res 1996;1l(Suppl 1): S 139.
Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulinlike growth factors. Annu Rev Physiol 1985;47:443–67.
Canalis E, McCarthy TL, Centrella M, Growth factors and cytokines in bone cell metabolism. Annu Rev Med 1991 ;42:17–24.
Schmid C, Ernst M. Insulin-like growth factors. In: Gowen M, editor. Cytokines and bone metabolism. Boca Raton, FL: CRC Press, 1992:229–65.
Caverzasio J, Montessuit C, Bonjour JP. Stimulatory effect of insulin-like growth factor-1 on renal P; transport and plasma 1,25-dihydroxyvitamin D3. Endocrinology 1990;127:453–9.
Caverzasio J, Bonjour JP. Insulin-like growth factors (IGF-1 and IGF-2) but not insulin selectively stimulate Na-dependent Pi transport activity in osteoblast-like cells. J Bone Miner Res 1990;5(Suppl 2):S 228.
Palmer G, Bonjour JP, Caverzasio J. Stimulation of inorganic phosphate transport by insulin-like growth factor-1 and vanadate ipossum kidney cells is mediated by distinct protein tyrosine phosphorylation processes. Endocrinology 1996;137:4699–705.
Daughaday WH, Trivedi B. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sei USA 1987;84:4636–40.
Merimee TJ, Zapf J, Hewlett B, Cavalli-Sforza LL. Insulin-like growth factors in pygmies. N Engl J Med 1987;316:906–11.
Hyer SL, Rodin DA, Tobias JH, Leiper A, Nussey SS. Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child 1992;67:1472–4.
Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency: role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996;81:3077–83.
Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987;80:706–10.
Kao PC, Matheny AP Jr, Lang CA. Insulin-like growth factor-1 comparisons in healthy twin children. J Clin Endocrinol Metab 1994;78:310–2.
Ammann P, Rizzoli R, Muller K. Slosman D, Bonjour JP. IGF-1 and Pamidronate increase bone mineral density in ovariectomized adult rats. Am J Physiol 1993;265:E770–6.
Ammann P, Rizzoli R, Meyer JM, Bonjour JP. Bone density and shape as determinants of bone strength in IGF-1 and/or pamidronate-treated ovariectomized rats. Osteoporos Int 1996;6:219–27.
Underwood LE. Reduced serum concentrations of insulin-like growth factor-1 (IGF-1) in protein-restricted growing rats are accompanied by reduced IGF-1 mRNA levels in liver and skeletal muscle. J Endocrinol 1991;130:305–12.
Cohick WS, Clemmons DR. the insulin-like growth factors. Annu Rev Physiol 1993;55:131–53.
Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3–34.
Chevalley T, Rizzoli R, Manen D, Caverzasio J, Bonjour JP. Arginine increases IGF-1 production and collagen synthesis in osteoblastic cells. J Bone Miner Res 1996;1l (Suppl 1):S 375.
Bachrach LK. Osteopenia in childhood and adolescence. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press, 1996:785–800.
Ferretti JL, Tessaro RD, Delgado CJ, Bozzini CE, Alippi RM, Barcelo AC. Biochemical performance of diaphyseal shafts and bone tissue of femur from protein-restricted rats. Bone Miner 1988;4:329–39.
Clavien H, Theintz G, Rizzoli R, Bonjour JP. Does puberty alter dietary habits in adolescents living in a Western society? J Adolescent Health 1996;19:68–75.
Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli, R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991;73:555–63.
Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spiine and femoral neck in female subjects. J Clin Endocrinol Metab 1992;75:1060–5.
Bonjour JP, Theintz G, Law F, Slosman D, Rizzoli R. Peak bone mass. Osteoporos Int 1994; 4(Suppl 1):7–14.
Geinoz G, Rapin CH, Rizzoli R, Kraemer R, Buchs B, Slosman D, et al. Relationship between bone mineral density and dietary intakes in the elderly. Osteoporos Int 1993;3:242–8.
Garn SM, Guzman MA, Wagner B. Subperiostal gain and endosteal loss in protein-calorie malnutrition. Am J Phys Anthropol 1969;30:153–5.
Parfitt AM, Miller MJ, Frame B, et al. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med 1978;89:193–200.
Seeman E, Riggs BL. Dietary prevention of bone loss in the elderly. Geriatrics 1981;36:71–9.
Garn SM, Kanzas J. Protein intake, bone mass, and bone loss. In: De Luca HF, Frost H, Jee W, Johnston C, Parfitt AM, editors. Osteoporosis: recent advances in pathogenesis and treatment. Baltimore: University Park Press, 1981:257–63.
Parfitt AM. Dietary risk factors for age-related bone loss and fractures. Lancet 1983;11:1181–4.
Schaafsma G, Van Beresteyn ECH, Raymakers JA, Duursma SA. Nutritional aspects of osteoporosis. World Rev Nutr Diet 1987;49:121–59.
Young GA, Chem C, Hill GL. Assessment of protein-calorie malnutrition in surgical patients from plasma proteins and anthropometric measurements. Am J Clin Nutr 1978;31:429–35.
Wooton RR, Brereton PJ, Clark MB, Hesp R, Hodkinson HM, Klenerman L, et al. Fractured neck of femur in the elderly: an attempt to identify patients at risk. Clin Sei 1979;57:93–101.
Rapin CH, Lagier R, Boivin G, Jung A, MacGee W. Biochemical findings in blood of aged patients with femoral neck fractures: a contribution to the detection of occult osteomalacia. Calcif Tissue Int 1982;34:465–9.
Bastow MD, Rawlings J, Allison SP. Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. BMJ 1983;287:1589–92.
Bastow MD, Rawlings J, Allison SP. Undernutrition, hypothermia, and injury in elderly women with fractured femur: an injury response to altered metabolism? Lancet 1983;1:143–6.
Giaccaglia G, Malagu U, Antonelli M, Boschi S, Tabarroni I. II supporta nutrizionale negli intervenu di fratture dell’anca, nell’anziano: esperienze e risultati. Minerva Anesthesiol 1986;52:397–00.
Tinetti ME, Speechley M, Ginter SF. Risks factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701–7.
Delmi M, Rapin CH, Bengoa JM, Delmas PD, Vasey H, Bonjour JP. Dietary supplementation in elderly patients with fractured neck of the femur. Lancet 1990;335:1013–6.
Patterson BM, Cornell CN, Carbone B, Levine B, Chapman D. Protein depletion and metabolic stress in elderly patients who have a fracture of the hip. J Bone Joint Surg Am 1992;74:251–60.
Chevalley T, Rizzoli R, Nydegger V, Slosman D, Tkatch L, Rapin CH, et al. Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur. Osteoporos Int 1991;1:147–54.
Dawson-Hughes B. Calcium supplementation and bone loss: a review of controlled clinical trials. Am J Clin Nutr 1991;54:S 274–80.
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637–12.
Chevalley T, Rizzoli R, Nydegger V, Slosman D, Rapin CH, Michel JP, et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin D-replete elderly patients. Osteoporos Int 1994;4:245–52.
Morley JE, Miller DK. Malnutrition in the elderly. Hospital Practice 1992;27:95–116.
Munro H, Schlierf G. Nutrition of the elderly. Nestlé nutrition workshop series, 29. New York: Raven Press, 1992.
Hammerman MR. Insulin-like growth factors and aging. Endocrinol Metab Clin 1987;16:995–1011.
Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R. Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 1992;75:494–501.
Schiirch MA, Rizzoli R, Mermillod B, Vasey H, Michel JP, Bonjour JP. A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res 1996; 11:1935–42.
Sullivan DH, Patch GA, Walls RC, Lipschitz DA. Impact of nutrition status on morbidity in a select population of geriatric rehabilitation patients. Am J Clin Nutr 1990;51:749–58.
Tkatch L, Rapin CH, Rizzoli R, Slosman D, Nydegger V, Vasey, H, et al. Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr 1992;11:519–25.
Sullivan DH, Carter WJ. Insulin-like growth factor-1 as an indicator of protein-energy undernutrition among metabolically stable hospitalized elderly. J Am Coll Nutr 1994; 13:184–91.
Bonjour JP, Rizzoli R. Inadequate protein intake and osteoporosis: possible involvement of the IGF system. In: Burckhardt P, Heaney RP, editors. Challenges of modern medicine: nutritional aspects of osteoporosis ’94, vol 7. Ares-Serono Symposia Publications 1995:399–406.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bonjour, J.P., Schüren, M.A., Chevalley, T. et al. Protein intake, IGF-1 and osteoporosis. Osteoporos Int 7 (Suppl 3), 36–42 (1997). https://doi.org/10.1007/BF03194340
Issue Date:
DOI: https://doi.org/10.1007/BF03194340